Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq for AML samples

ABSTRACT: RNA-seq for AML samples

PROVIDER: PRJNA788455 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17215749_1.fastq.gz	Fastqsanger.gz
	SRR17215749_2.fastq.gz	Fastqsanger.gz
	SRR17215750_1.fastq.gz	Fastqsanger.gz
	SRR17215750_2.fastq.gz	Fastqsanger.gz
	SRR17215751_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

RNA-seq for AML samples

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to explore RNA-seq results for AML samples.

2022-07-20 | GSE190775 | GEO

RNA-seq of human AML patient samples with complex karyotype

Project description:RNA-seq of human AML patient samples with complex karyotype

| PRJEB79755 | ENA

Transcriptomic profiling of human AML cell lines and primary AML samples

Project description:We sequenced mRNA from both cell lines and primary samples to investigate transcriptomic profiles of human AML cell lines and primary samples. We then performed gene expression profiling analysis using data obtained from RNA-seq of AML cell lines and primary samples that have sphingolipidomic characterization to identify transcriptional differences between two distinct sphingolipidomic subtypes in AML samples.

2024-01-14 | GSE229032 | GEO

RNA-seq on AML patient samples and umbilical cord blood derived CD34+

Project description:RNA-seq on AML patient samples and umbilical cord blood derived CD34+

| PRJNA529361 | ENA

RNA-seq of human AML patient samples with complex karyotype

Project description:Acute myeloid leukemia with complex karyotype (CK-AML) is characterized by three or more chromosomal aberrations, and comprises 10–12% of AML patients. It is associated with complex chromosomal rearrangements, intra-tumor heterogeneity, therapy resistance and poor overall survival. We aimed to transcriptionally characterize CK-AML by performing RNA sequencing on blasts from 4 CK-AML patient samples.

2024-09-20 | E-MTAB-14420 | biostudies-arrayexpress

miR196b-/- DNMT3A-mutant AML [RNA-seq]

Project description:miR196b-/- DNMT3A-mutant AML [RNA-seq]

| PRJNA792547 | ENA

RNA-seq of NK cells from blood samples of HV and AML patients

Project description:CD56neg CD16+ Natural Killer (NK) cells have been reported to expand in chronic diseases and acute myeloid leukemia (AML). However, their biological role is still unclear. Using bulk RNA-sequencing, we compared gene expression profile of CD56neg CD16+ NK cells with conventional CD56bright, CD56dim CD16- and CD56dim CD16+ NK cells from blood samples of HV and AML patients. RNA-seq unveiled that CD56neg CD16+ NK cells were mature circulating NK cells with functional capacities. Taken together, our results suggest that CD56neg CD16+ NK cells are a relevant target for future NK-cell-based immunotherapies.

2024-12-20 | E-MTAB-14569 | biostudies-arrayexpress

RNA-seq of LSC-like and Mature populations from human AML patient samples

Project description:RNA-seq of LSC-like and Mature populations from human AML patient samples

| PRJEB54896 | ENA

RNA-Seq Analysis

Project description:RNA-Seq analysis carried out in three different backcrosses based on Iberian breed with Landrace, Pietrain and Duroc breeds

2017-10-31 | PRJEB23068 | EVA

Bulk RNA-seq profiles of primary AML samples corresponding to existing scRNA-seq data from GSE116256

Project description:Bulk RNA-seq profiles of primary AML samples corresponding to existing scRNA-seq data from GSE116256

| PRJNA820016 | ENA